Rational or rationalized choices in fluid resuscitation?

by Han, Jenny, Martin, Greg S
Published 2010

Safety and tolerability of exenatide twice daily in patients with type 2 diabetes: integrated analysis of 5594 patients from 19 placebo-controlled and comparator-controlled clinica...

by MacConell, Leigh, Brown, Carl, Gurney, Kate, Han, Jenny
Published 2012

Efficacy and Tolerability of Exenatide Once Weekly Over 6 Years in Patients with Type 2 Diabetes: An Uncontrolled Open-Label Extension of the DURATION-1 Study

by Henry, Robert R., Klein, Eric J., Han, Jenny, Iqbal, Nayyar
Published 2016

Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes

by Ratner, Robert, Han, Jenny, Nicewarner, Dawn, Yushmanova, Irina, Hoogwerf, Byron J, Shen, Larry
Published 2011

Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years

by Taylor, Kristin, Gurney, Kate, Han, Jenny, Pencek, Richard, Walsh, Brandon, Trautmann, Michael
Published 2011

Vitamin D and sepsis: An emerging relationship

by Kempker, Jordan A., Han, Jenny E., Tangpricha, Vin, Ziegler, Thomas R., Martin, Greg S.
Published 2012

Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals

by Meloni, Alison R, DeYoung, Mary Beth, Han, Jenny, Best, Jennie H, Grimm, Michael
Published 2013

Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis

by Gaebler, Julia A, Soto-Campos, Gerardo, Alperin, Peter, Cohen, Marc, Blickensderfer, Amy, Wintle, Matthew, Maggs, David, Hoogwerf, Byron, Han, Jenny, Pencek, Richard, Peskin, Barbara
Published 2012

Exenatide at therapeutic and supratherapeutic concentrations does not prolong the QTc interval in healthy subjects

by Darpö, Börje, Sager, Philip, MacConell, Leigh, Cirincione, Brenda, Mitchell, Malcolm, Han, Jenny, Huang, Wenying, Malloy, Jaret, Schulteis, Christine, Shen, Larry, Porter, Lisa
Published 2013

Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non–Small Cell Lung Cancer Cells1

by Saygideğer-Kont, Yasemin, Minas, Tsion Zewdu, Jones, Hayden, Hour, Sarah, Çelik, Haydar, Temel, Idil, Han, Jenny, Atabey, Nese, Erkizan, Hayriye Verda, Toretsky, Jeffrey A., Üren, Aykut
Published 2016

High dose vitamin D administration in ventilated intensive care unit patients: A pilot double blind randomized controlled trial

by Han, Jenny E., Jones, Jennifer L., Tangpricha, Vin, Brown, Mona A., Hao, Li, Hebbar, Gautam, Lee, Moon Jeong, Liu, Shuling, Brown, Lou Ann S., Ziegler, Thomas R., Martin, Greg S.
Published 2016

Androgens Regulate Prostate Cancer Cell Growth via an AMPK-PGC-1α-Mediated Metabolic Switch

by Tennakoon, Jayantha B., Shi, Yan, Han, Jenny J., Tsouko, Efrosini, White, Mark A., Burns, Alan R., Zhang, Aijun, Xia, Xuefeng, Ilkayeva, Olga R., Xin, Li, Ittmann, Michael M., Rick, Ferenc G., Schally, Andrew V., Frigo, Daniel E.
Published 2013

YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model

by Minas, Tsion Zewdu, Han, Jenny, Javaheri, Tahereh, Hong, Sung-Hyeok, Schlederer, Michaela, Saygideğer-Kont, Yasemin, Çelik, Haydar, Mueller, Kristina M., Temel, Idil, Özdemirli, Metin, Kovar, Heinrich, Erkizan, Hayriye Verda, Toretsky, Jeffrey, Kenner, Lukas, Moriggl, Richard, Üren, Aykut
Published 2015

A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model

by Rahim, Said, Minas, Tsion, Hong, Sung-Hyeok, Justvig, Sarah, Çelik, Haydar, Kont, Yasemin Saygideger, Han, Jenny, Kallarakal, Abraham T., Kong, Yali, Rudek, Michelle A., Brown, Milton L., Kallakury, Bhaskar, Toretsky, Jeffrey A., Üren, Aykut
Published 2014